Study on the dose-response of a jelly preparation of polystyrene sulfonate calcium in hyperkalemia

Therapeutic Research

Volumn 26, Issue 8, 2005, Pages 1727-1733

  Wakabayashi, Michiro ^a   Shou, Ichiyu ^a   Satake, Kenji ^a   Seto, Takuya ^a   Maeda, Kunimi ^a   Tanaka, Yuichi ^a   Nakata, Junichiro ^a   Shimaoka, Tetsutaro ^a   Tomino, Yasuhiko ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGAMATE; CREATININE; ELECTROLYTE; MAGNESIUM; POLYSTYRENESULFONATE CALCIUM; POTASSIUM;

ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DOSE RESPONSE; ELECTROLYTE BLOOD LEVEL; HUMAN; HYPERKALEMIA; MAGNESIUM BLOOD LEVEL; POTASSIUM BLOOD LEVEL;

EID: 25144442635     PISSN: 02898020     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Jarman PR, Kehely AM, Mather HM. Hyperkalaemia in diabetes: prevalence and associations. Postgrad Med J 1995;71:551-2.
2. Brenner BM, Cooper ME, Zeeuw D, Keane WC Mitch WE, Parving HH. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345:861-9.
3. Reardon LC, Macpherson DS. Hyperkalemia in outpatients using angiotensin-converting enzyme inhibitors. Arch Intern Med 1998;158:26-32.